ENTITY
Peijia Medical

Peijia Medical (9996 HK)

82
Analysis
Health Care • China
Peijia Medical is a China-based company specializing in the research, development, and manufacturing of high-end interventional medical devices. It provides comprehensive treatment solutions for structural heart diseases, including transcatheter aortic valve replacement (TAVR) systems, and neurovascular diseases with various neurointerventional devices. The company was founded in 2012 and is headquartered in Suzhou, China.
more
bullish•Kangji Medical
•16 Jun 2020 00:25

Kangji Medical IPO: Valuation Insights

Kangji Medical (1498779D CH) is the largest domestic minimally invasive surgical instruments and accessories (MISIA) platform in China, with a 2.7%...

Logo
520 Views
Share
•11 Jun 2020 16:58

Venus Medtech Lock-Up Expiry: Could Face Selling Pressure

Venus Medtech is a dominant player in the heart valve replacement (TAVR) market in China and was listed in Hong Kong on December 10th. Since...

Logo
601 Views
Share
bullish•Kangji Medical
•11 Jun 2020 11:27

Kangji Medical (åŗ·åŸŗåŒ»ē–—) Pre-IPO: COVID-19 Impacts and Thoughts on Valuation

Kangji Medical is a domestic leader in minimally invasive surgery devices. It has three main product types, trocars, polymer ligation clips, and...

Logo
757 Views
Share
•06 Jun 2020 04:07

HKEx (388.HK): Trading Volume in May Points to Upside and New License Agreement with MSCI

HKEX (388 HK) just released its May market statistics. The May month ADT (Average Daily Turnover) has registered 14% month-to-month rebound to HKD...

Logo
Roger Xie
582 Views
Share
•17 May 2020 12:55

ECM Weekly (17 May 2020) -Dada Nexus, Kintor Pharma, Yeahka, Archosaur Games

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming...

Share
x